Gender-based disparities in clinical presentation and outcomes of benign thyroid nodules
Elisa Mattii, Fabio Maino, Alfonso Sagnella, Laura Valerio et autres
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
Elisa Mattii, Fabio Maino, Alfonso Sagnella, Laura Valerio et autres
Sonia Caprio, Tania Pilli, Silvia Cantara, Fausta Sestini et autres
PURPOSE: An increase of IGF-1 has been reported during therapy with dopamine agonists (DA) for prolactinomas; in such cases a correct diagnosis is pivotal to avoid an unnecessary reduction or withdrawal of DA, which are needed to maintain normal prolactin levels. This …
it (code pays fourni par la source)
Cristina Dalmiglio, Raffaella Forleo, Noemi Fralassi, Fabio Maino et autres
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
Tania Pilli, Cristina Dalmiglio, Gilda Dalmazio, Alfonso Sagnella et autres
Objective: Coronavirus disease-2019 (COVID-19) causes acute respiratory distress syndrome. Patients with adrenal insufficiency (AI) may develop severe complications due to this infection and should undergo COVID-19 vaccination; however, there is no consensus about the management of their replacement therapy. The aim of …
it (code pays fourni par la source)
Marco Capezzone, Alfonso Sagnella, Silvia Cantara, Noemi Fralassi et autres
Introduction Survival rates in patients with non-medullary thyroid carcinoma (NMTC) are high, increasing the possibility to develop a second malignant neoplasm (SMN). Many studies investigated the relationship between increased risk of SMN in NMTC patients treated with radioiodine, but few data are …
it (code pays fourni par la source)
Tania Pilli, Gilda Dalmazio, Brunetta Porcelli, Silvia Cantara et autres
Background: Autoimmune diseases tend to cluster in the same individual or in families. Four types of autoimmune polyglandular syndromes (APS) have been described based on the combination of endocrine and/or non-endocrine autoimmune diseases. In particular, type-3 APS is defined by the association …
it (code pays fourni par la source)
Marco Capezzone, Silvia Cantara, Andrea Di Santo, Alfonso Sagnella et autres
Introduction The management of patients with indeterminate thyroid nodules, which account for 10–25% of thyroid fine needle aspiration biopsies (FNABs), is still very challenging. Aim To verify the utility of the seven-gene panel in combination with ultrasound features in the clinical management …
it (code pays fourni par la source)
Marco Capezzone, Fabio Maino, Alfonso Sagnella, M Campanile et autres
it (code pays fourni par la source)
Lucia Brilli, Cristina Dalmiglio, Tania Pilli, Filomena Barbato et autres
Background: Tyrosine kinase inhibitors (TKIs) have improved progression-free survival in patients with advanced thyroid cancer. So far, few studies have investigated the efficacy of TKIs in a second-line setting. The purpose of our study was to explore the salvage therapy efficacy in …
it (code pays fourni par la source)
Tania Pilli, Sandro Cardinale, Silvia Cantara, Gilda Dalmazio et autres
it (code pays fourni par la source)
Lucia Brilli, Riccardo Danielli, M Campanile, Chiara Secchi et autres
PURPOSE: Immunotherapy against immune checkpoints has significantly improved survival both in metastatic and adjuvant setting in several types of cancers. Thyroid dysfunction is the most common endocrine adverse event reported. Patients who are at risk of developing thyroid dysfunction remain to be …
it (code pays fourni par la source)
Lucia Brilli, Tania Pilli, Furio Pacini, Maria Grazia Castagna
it (code pays fourni par la source)
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.
L'essentiel de l'actu tech du Burkina & d'Afrique, chaque semaine dans votre boîte mail.
Gratuit · sans spam · désinscription en un clic